| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000009148 |
| Receipt No. | R000010725 |
| Official scientific title of the study | The effect of elastic stocking on the leg lymph function assessed by indocyanine-green-fluorescence lymph vessel imaging |
| Date of disclosure of the study information | 2012/10/22 |
| Last modified on | 2016/04/20 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | The effect of elastic stocking on the leg lymph function assessed by indocyanine-green-fluorescence lymph vessel imaging | |
| Title of the study (Brief title) | Assessment of the effect of elastic stocking on lymph pumping pressure and general health performance | |
| Region |
|
|
| Condition | ||
| Condition | Perturbance of lymph perfusion | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Assessment of the effect of elastic stocking on lymph pumping pressure and general health performance |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | indocyanine green fluorescence lymphography, lymphatic pumping pressure
SF-36 interview |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Recrute healthy volunteers with leg lymph pumping less than 20 mmHg lymph ejection pressure fell to 20 or less mmHg. Test the effect of elastic stocking on the improvement of leg lymph pumping and general health condition after 4 months. | |
| Interventions/Control_2 | Control group with non elastic stocking | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | healthy volunteers whom lymph ejection pressure fell to 20 or less mmHg | |||
| Key exclusion criteria | chronic venous insufficiency (CVI) such as varicose vein and deep vein thrombosis,
People with past medical history of leg injury, patients with secondary lymphedema (pelvic surgery such as uterus, prostate, and rectal surgery) |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Unno |
| Organization | Hamamatsu University School of Medicine |
| Division name | Vascular surgery |
| Address | Hamamatsu University School of Medicine,1-20-1Handayama,Higashi-ku,Hamamatsu-shi, Shizuoka, 431-3125, Japan |
| TEL | 053-435-2273 |
| r.sugisawa@gmail.com | |
| Public contact | |
| Name of contact person | Ryota Sugisawa |
| Organization | Hamamatsu University School of Medicine, |
| Division name | Vascular surgery |
| Address | Hamamatsu University School of Medicine,1-20-1Handayama,Higashi-ku,Hamamatsu-shi, Shizuoka, 431-3125 |
| TEL | 053-435-2273 |
| Homepage URL | |
| r.sugisawa@gmail.com | |
| Sponsor | |
| Institute | Hamamatsu University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Toray Opelontex Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010725 |